Related Experiment Video
Updated: Mar 10, 2026
06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
15.0K
Chikungunya in the Americas: Recommendations and Conclusions
Barney S Graham1, Patricia M Repik2, Sergio Yactayo3
1Vaccine Research Center.
The Journal of Infectious Diseases
|December 7, 2016
Summary
Chikungunya virus (CHIKV) causes significant illness globally. Experts convened to review current knowledge and identify research gaps for developing effective vaccines and treatments against this mosquito-borne virus.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Chikungunya virus (CHIKV), discovered in 1953, has a history of circulation in Africa and Southeast Asia.
- A 2005 genetic mutation significantly enhanced CHIKV transmission, leading to its global spread.
- CHIKV infection poses a substantial public health burden due to high morbidity, with no current licensed vaccines or specific treatments.
Purpose of the Study:
- To enhance understanding of chikungunya virus.
- To identify existing knowledge gaps regarding CHIKV.
- To guide the development of more effective interventions and treatments.
Main Methods:
- Convened global experts in virology, epidemiology, and public health.
- Conducted a comprehensive review of existing chikungunya virus research.
- Facilitated expert discussions to identify critical research needs.
Main Results:
- Identified key areas requiring further investigation in CHIKV pathogenesis and transmission.
- Highlighted the urgent need for novel therapeutic strategies.
- Outlined priorities for vaccine development research.
Conclusions:
- A coordinated global effort is essential for advancing CHIKV research.
- Further studies are crucial to address the significant morbidity and public health impact of CHIKV.
- The review provides a roadmap for future research and intervention development.
